Metastasis is responsible for 90% of human cancer mortality, yet it remains a challenge to model human cancer metastasis in vivo. Here we describe mouse models of high-grade serous ovarian cancer, also known as high-grade serous carcinoma (HGSC), the most common and deadliest human ovarian cancer type. Mice genetically engineered to harbor Dicer1 and Pten inactivation and mutant p53 robustly replicate the peritoneal metastases of human HGSC with complete penetrance. Arising from the fallopian tube, tumors spread to the ovary and metastasize throughout the pelvic and peritoneal cavities, invariably inducing hemorrhagic ascites. Widespread and abundant peritoneal metastases ultimately cause mouse deaths (100%). Besides the phenotypic and hist...
Background: Recently, new paradigms for the etiology and origin of ovarian high-grade serous carcino...
Purpose: Preclinical models of epithelial ovarian cancer have not been exploited to evaluate the cli...
PURPOSE: Preclinical models of epithelial ovarian cancer have not been exploited to evaluate the cli...
Metastasis is responsible for 90% of human cancer mortality, yet it remains a challenge to model hum...
Metastasis is responsible for 90% of human cancer mortality, yet it remains a challenge to model hum...
Serous epithelial ovarian cancer (SEOC) is the most lethal gynecological cancer in the United States...
Ovarian cancer is the most common cause of death from gynecological cancer. Understanding the biolog...
Recent evidence suggests that ovarian high-grade serous carcinoma (HGSC) originates from the epithel...
Epithelial ovarian cancer (EOC) is a deadly gynecologic malignancy, but animal models for the study ...
BackgroundPeritoneal carcinomatosis is a hallmark of advanced peritoneal tumor progression, particul...
AbstractTransgenic mouse model faithfully reproduces human ovarian carcinoma and offers new opportun...
For over five decades epithelial ovarian cancer (EOC) is identified as the leading cause of death fr...
Abstract Background Intraperitoneal (i.p.) models that accurately mimic the feature behavior of huma...
Recent studies have suggested that the most common and lethal type of ‘ovarian’ cancer, i.e. high‐gr...
Purpose: Preclinical models of epithelial ovarian cancer have not been exploited to evaluate the cli...
Background: Recently, new paradigms for the etiology and origin of ovarian high-grade serous carcino...
Purpose: Preclinical models of epithelial ovarian cancer have not been exploited to evaluate the cli...
PURPOSE: Preclinical models of epithelial ovarian cancer have not been exploited to evaluate the cli...
Metastasis is responsible for 90% of human cancer mortality, yet it remains a challenge to model hum...
Metastasis is responsible for 90% of human cancer mortality, yet it remains a challenge to model hum...
Serous epithelial ovarian cancer (SEOC) is the most lethal gynecological cancer in the United States...
Ovarian cancer is the most common cause of death from gynecological cancer. Understanding the biolog...
Recent evidence suggests that ovarian high-grade serous carcinoma (HGSC) originates from the epithel...
Epithelial ovarian cancer (EOC) is a deadly gynecologic malignancy, but animal models for the study ...
BackgroundPeritoneal carcinomatosis is a hallmark of advanced peritoneal tumor progression, particul...
AbstractTransgenic mouse model faithfully reproduces human ovarian carcinoma and offers new opportun...
For over five decades epithelial ovarian cancer (EOC) is identified as the leading cause of death fr...
Abstract Background Intraperitoneal (i.p.) models that accurately mimic the feature behavior of huma...
Recent studies have suggested that the most common and lethal type of ‘ovarian’ cancer, i.e. high‐gr...
Purpose: Preclinical models of epithelial ovarian cancer have not been exploited to evaluate the cli...
Background: Recently, new paradigms for the etiology and origin of ovarian high-grade serous carcino...
Purpose: Preclinical models of epithelial ovarian cancer have not been exploited to evaluate the cli...
PURPOSE: Preclinical models of epithelial ovarian cancer have not been exploited to evaluate the cli...